Event Date: May 09, 2018
This webinar will cover understandings of sex and gender, sex differences in Alzheimer’s disease, how the higher number of women with AD may be due to both, and a discussion of the role of estrogens in the health of brain regions associated with Alzheimer’s disease.
This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA).
Gillian Einstein, PhD
Gillian Einstein is The Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging, Professor of Psychology at the University of Toronto and Guest Professor of Gender and Health at Linköping University in Linköping, Sweden. Her broader interests encompass memory, the long term effects of hormone treatment, and the bridge between our scientific understanding of the nervous system and larger concerns having to do with self, identity, feminism, and the nature of science.
Dr. Einstein received her AB from Harvard University and her PhD from the University of Pennsylvania where she studied visual neuroanatomy. She has published on Alzheimer disease, vision, sex differences, and estrogens’ effects on pain, sleep, memory and mood. Her current research is on the effects of estrogens and culture on women’s biologies and she is funded to study cognitive and brain changes in young women who have had their ovaries removed before natural menopause. The overarching question of this research is: How do both sex and gender mediate women’s brain health?
Dr. Einstein edited and annotated a book on foundational papers in Hormones and Behaviour, Sex and the Brain (MIT Press). She is founder and director from 2006-2016 of the Collaborative Specialization in Women’s Health, a founding member of the Organization for the Study of Sex Differences and its first treasurer, and is currently a member of the board of the International Society for Gender Medicine. She has served as member and then, Chair of the Scientific Advisory Board for the Institute of Gender and Health of the Canadian Institutes of Health Research (2010-2016) and is now, again, Chair of the IGH Advisory Board as well as a Member of the CIHR College of Reviewers.